Efficacy and safety of single agent pan-HER inhibitor dacomitinib in locally advanced unresectable or metastatic skin squamous cell cancer (sSCC).

Bossi, ; Paolo, ; Cavalieri, ; Stefano, ; Perrone, ; Federica, ; Miceli, ; Rosalba, ; Ascierto, ; Paolo, Antonio; Locati, ; Laura, D.; Bergamini, ; Cristiana, ; Granata, ; Roberta, ; Alfieri, ; Salvatore, ; Resteghini, C; Galbiati, ; Donata, ; Busico, ; Adele, ; Paielli, ; Nicholas, ; Patuzzo, ; Roberto, ; Maurichi, ; Andrea, ; Gallino, ; Gianfranco, ; Ruggeri, ; Roberta, ; Mariani, ; Luigi, ; Palla, ; Marco, ; Licitra, ; Lisa,